Scientists probe why PAH strikes women more, test if common diabetes drug can help
NCT ID NCT01884051
Summary
This research aims to better understand the underlying causes of pulmonary arterial hypertension (PAH), a serious lung and heart condition. It has three main goals: to study why women get PAH more often than men, to test if the diabetes drug metformin can help by improving how the body uses energy, and to evaluate the safety of a potential new drug called ACE2. The study will involve nearly 1,900 participants, including people with PAH and their family members, to gather information that may lead to future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.